Skip to content
buyWeak cluster of 4

Pamela W. Montgomery bought $7,021 of NUTX

Chief Legal Officer-Healthcare at Nutex Health, Inc.. 79 shares at an average of $88.87, traded Mar 13, 2026, filed Mar 16, 2026.

Conviction score
38
Value
$7,021
79 shares
Holdings after
2,758
+3% from before
From 52-week low
+94%
low $45.68, close $88.80
From 52-week high
-53%
high $190.49, as of Mar 13, 2026

Score components

  • Role
    Officer
    +15
  • Trade size
    $7k at market
    0
  • Relative to holdings
    Holdings up 2.9%
    0
  • Price context
    53% below the 52-week high
    +8
  • Cluster
    4 insiders buying within 14 days
    +15
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +17.6%, 3m +58.7%, 6m +134.1%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

NUTXOct 12, 2026 · close 206.15
Since filing Mar 16, 2026: +122.4%SPY +17.2% · excess +105.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001919434-26-000002, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 13, 2026POpen-market purchase
Common Stock
+79$88.87$7,0212,758Mar 16, 2026
Mar 10, 2026MOption exercise
Restricted Stock Unitderivative
+1,523$0.00$04,441Mar 16, 2026

Related signals

Other insiders at Nutex Health, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
31Weak
NUTXsell
Nutex Health, Inc.
Scott J Saunders
director
$43k
203 shares
-34%
43Moderate
NUTXbuy 4
Nutex Health, Inc.
Warren Hosseinion
President
$24k
252 shares
+3%
46Moderate
NUTXbuy 4
Nutex Health, Inc.
Frank E Jaumot
director
$14k
150 shares
-
33Weak
NUTXbuy 4
Nutex Health, Inc.
Kelvin Spears
director
$945
10 shares
+0%
43Moderate
NUTXbuy
Nutex Health, Inc.
Jon Christian Bates
Chief Financial Officer
$103k
750 shares
+15%
37Weak
NUTXbuy
Nutex Health, Inc.
Jon Christian Bates
Chief Financial Officer
$82k
1,000 shares
+26%
48Moderate
NUTXbuy
Nutex Health, Inc.
Joshua DeTillio
Chief Operating Officer
$11k
20,000 shares
+214%
46Moderate
NUTXbuy 2
Nutex Health, Inc.
Thomas T. Vo
Chief Executive Officer
$114k
500,000 shares
+0%
50Moderate
NUTXbuy 2
Nutex Health, Inc.
Joshua DeTillio
Chief Operating Officer
$34k
140,000 shares
-

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Pamela W. Montgomery bought $7,021 of NUTX | InsiderTell